AZD8075 Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Oral Doses of AZD8075 in Healthy Male Volunteers

NCT00829127 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

27

Enrollment

INDUSTRY

Sponsor class

Stopped Due to termination of study D3801C00001, due to reports of turbid urine.

Conditions

Healthy

Interventions

DRUG: AZD8075
DRUG: Placebo

Sponsor

AstraZeneca